PetCaseFinder

Peer-reviewed veterinary case report

Protective efficacy of an inactivatedvaccine candidate lysed by GI24 against brucellosis in Korean black goats.

Journal:
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire
Year:
2019
Authors:
Kim, Wong-Kyong et al.
Affiliation:
College of Veterinary Medicine · South Korea

Abstract

The efficacy of GI24-lysedcells as a vaccine candidate against brucellosis in goats was evaluated on 2 groups of Korean black goats. Group A goats were immunized subcutaneously (SC) with sterile phosphate-buffered saline, whereas group B goats were immunized SC with approximately 3 × 10lysedcells. Subcutaneous immunization with the lysed cells did not cause any negative impact on the overall clinical status, such as behavior and appetite, throughout the study period. The enzyme-linked immunosorbent assay (ELISA) optical densities values forlipopolysaccharide in serum were considerably higher in group B than those in group A. Also, the levels of the cytokines interleukin 4 (IL-4), tumor necrosis factor-alpha (TNF-α), and interferon gamma (IFN-γ) were significantly elevated in group B compared with those in group A. Following intraconjunctival challenge withstrain 544, the severity of brucellosis in terms of infection index and colonization ofin tissues was significantly lower in group B than in group A. The present study concluded that 3 of 5 goats immunized with GI24-lysed bacteria were completely protected against challenge. Future investigations are required to improve the protective efficacy offered by lysedcells for practical applications in small ruminants.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/30670904/